GC Aesthetics Announces the Launch of FixNip: a Total Game-Changer in Breast Reconstruction

GC Aesthetics, Inc. (GCA), a privately-held medical technology company providing Healthcare Aesthetic Solutions, announced the launch of an Innovative Nipple Areola Complex (NAC) Reconstruction Implant : FixNip NRI.

Latest Aithority Insights: Auterion Delivers Supercomputer Performance Onboard Drones and Mobile Robots With AI Node

This unrivalled medical device is the answer to a well-known clinical need of thousands of women around the world. Until now, a variety of surgical techniques are used to try to reconstruct the nipple areola complex with none providing a long term aesthetic solution.

GC Aesthetics in an exclusive partnership agreement with FixNip LTD is proud of launching FixNip NRI in main European Territories, while the roll-out to Latin America, Central Europe and Asia will be announced later this year.

“We are committed to deliver safe options that establish a newer, higher, and more beneficial standard of care for women who seek to total breast reconstruction. Such technology breakthrough will complete our range of solutions dedicated to women aesthetic healthcare. FixNip by GC Aesthetics is a healthcare game-changer” said Carlos Reis Pinto, CEO of GC Aesthetics.

Browse The Complete News About Aithority : TaskHuman Adds 1:1 Sales Coaching to Accelerate Time to Revenue for Global Sales Teams

With this one-of-a-kind-product GC Aesthetics will spearhead expansion and growth into the Breast Reconstruction Segment, elevating and enhancing current standards.

“The NAC reconstruction procedure should be considered an integral part of the breast reconstructive surgery. It gives women an important psychological contribution and leads a greater well-being, overall sense of self and high satisfaction after being reconstructed. As a leader of the GCA multi-centric safety and efficacy trial, I am highly satisfied with the results” added Prof. Dr. Michael Atlan, renowned French Plastic Surgeon.

The GC Aesthetics FixNip NRI is implanted with a minimally invasive procedure done by a Surgeon in average in 15 minutes. The outcome has been demonstrating a high patient satisfaction with a minimum patient down time and an excellent safety profile.

“At GCA we believe a Total Breast Reconstruction is not only a choice, but a pathway for women to a full recovery after a mastectomy. We are extremely proud of adding this product to our portfolio and what it will represent for Reconstructive and Plastic Surgeons and the lives of thousands of women.” Mentioned Fara Naomi Macías, CMO of GCA

Read More About Aithority News : Milesight Blossoms into Mighty AIoT Solution Provider with Leading-Edge Products and Solutions

[To share your insights with us, please write to sghosh@martechseries.com]